 |
B.AS., Biology, Loyola University, MD
|
|
Research Interests |
After graduating from Loyola University in Maryland, I worked at two biopharmaceutical companies focused on discovering novel immunotherapies to combat cancer. Initially, my research focused on investigating the biology of the immunosuppressive Siglec-15-expressing myeloid cells in the tumor microenvironment. Recently, I have been working on developing a screening platform to assess the ability of various immune checkpoint bispecific antibodies to reverse T cell suppression in the tumor microenvironment. More generally, my research interests revolve around cancer immunology and cancer stem cells. |
|
Publications |
|
|
Presentations |
Archer, K., Ceradoy, J., Coupet, T., Bosiacki, J., Song, C., Weiss, I., Niu, S., Obot, T., Xu, J., O'Neill, T., Ferrell, A., Abukharma, H., Cusumano, Z., Flies, D., Langermann, S., and Liu. L.N. (2021). Development and Functional Characterization of NC762, a Novel Therapeutic Antibody Targeting B7-H4, for the Treatment of Malignancies. P3193. Poster presented at: American Association for Cancer Research (AACR) Annual Meeting; 2021 Apr 10; Virtual. Liu, L.N., Wang, J., Sun, J., Flies, D., Song, C., Zarr, M., Archer, K., McGuire, A., O'Neill, T., Maloveste, K., Nie, X., Boto, A., Copeland, R., Janardhanan, S., Obot, T., Bingham, J., Heller, K.N., Langermann, S., and Chen, L. (2018). Targeting Siglec-15 with NC318: a Novel Therapeutic Antibody to Enhance Anti-Tumor Immunity. P678. Poster presented at: Society for Immunotherapy of Cancer 33rd Annual Meeting; 2018 Nov 9-10; Washington, DC. |
| Awards |
2023 Eckard Wimmer Graduate Student Scholarship 2023 Outstanding Poster Award; Annual Retreat, Department of Microbiology and Immunology, Stony Brook University. |
